Back
Blueprint Chesapeake Multi-Asst Trnd ETF Vs. Avidity Biosciences Industry Stock Comparison
Sell
40
TFPN
Blueprint Chesapeake Multi-Asst Trnd ETF
Last Price:
25.13
Seasonality Move:
-0.16%
Sell
28
RNA
Avidity Biosciences
Last Price:
41.33
Seasonality Move:
39.98%
Sell
40
Blueprint Chesapeake Multi-Asst Trnd ETF (TFPN)
is a Sell
Is Blueprint Chesapeake Multi-Asst Trnd ETF a Buy, Sell or Hold?
- The current Blueprint Chesapeake Multi-Asst Trnd ETF [TFPN] share price is $24.85. The Score for TFPN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- TFPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TFPN Stock Price Chart
What is Blueprint Chesapeake Multi-Asst Trnd ETF's stock price today?
-
The Blueprint Chesapeake Multi-Asst Trnd ETF share price today is $24.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFPN is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $42.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
TFPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 53.41 | Buy |
Chaikin Money Flow: | -8363 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.26 - 25) | Buy |
Bollinger Bands (100): | (23.94 - 25.18) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 42.17 | Sell |
Chaikin Money Flow: | -1839481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.78 - 48.76) | Sell |
Bollinger Bands (100): | (41.56 - 46.96) | Sell |
TFPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.1 | Sell |
20-day SMA: | 24.65 | Buy |
50-day SMA: | 24.42 | Buy |
200-day SMA: | 24.99 | Sell |
8-day EMA: | 25 | Sell |
20-day EMA: | 24.77 | Buy |
50-day EMA: | 24.57 | Buy |
200-day EMA: | 23.71 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.51 | Sell |
20-day SMA: | 45.87 | Sell |
50-day SMA: | 45.1 | Sell |
200-day SMA: | 34.2 | Buy |
8-day EMA: | 46.84 | Sell |
20-day EMA: | 46.32 | Sell |
50-day EMA: | 45.24 | Sell |
200-day EMA: | 35.58 | Buy |
Blueprint Chesapeake Multi-Asst Trnd ETF Earnings Growth & TFPN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.24 per share.
Blueprint Chesapeake Multi-Asst Trnd ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |